Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Timolol eye-drops can cause hair loss.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

Higher CRBP1 levels are linked to more severe alopecia areata.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The new hair follicle harvesting technique improves hair transplant results and makes the procedure quicker and easier to learn.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.